Inventor
LILI FENG
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07DHeterocyclic compounds14%
H01LSemiconductor devices14%
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h1014%
C07CAcyclic or carbocyclic compounds7%
C07HSugars7%
H10DInorganic electric semiconductor devices7%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h107%
PatentTitleYear
11,881,402Self aligned multiple patterning202411,869,807Fully self-aligned subtractive etch202411,642,329Amorphous solid form of compounds containing S--N-valeryl-N- {[2'-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations2023RE049080Glycoside derivatives and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to NOVARTIS AG (1)· patent assignee history
2022–2024Based in US· patent location history
2023Patents assigned to NOVARTIS PHARMACEUTICALS CORP (1)· patent assignee history
2024Patents assigned to APPLIED MATERIALS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| APPLIED MATERIALS INC | 2 | 2024 |
| NOVARTIS AG | 1 | 2022 |
| NOVARTIS PHARMACEUTICALS CORP | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2024 |